Inventor · disambiguated record
Adriano Afonso
Also filed as: AFONSO ADRIANO
41 granted patents·1 pending application·903 citations·filing 1978–2007
98Inventor score
Top patents by PatentIndex Score
42 records- 0194US5801175ATricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1996·Granted Sep 1, 1998·68 cites·35 claims
- 0294US5412104AEster and alkoxy substituted benzopyransSCHERING CORP·Filed 1991·Granted May 2, 1995·59 cites·3 claims
- 0394US5175151AAntiviral compounds and antihypertensive compoundsSCHERING CORP·Filed 1992·Granted Dec 29, 1992·69 cites·8 claims
- 0493US5672611ATricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Sep 30, 1997·62 cites·27 claims
- 0592US5880128ACarbonyl piperazinyl and piperidinyl compoundsSCHERING CORP·Filed 1996·Granted Mar 9, 1999·77 cites·11 claims
- 0691US6124295ACompounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1999·Granted Sep 26, 2000·47 cites·18 claims
- 0789US5190956ACertain N-substituted 3-oximino-2,4-dioxoquinolin-2,4-(1H)diones useful for treating viral infectionsSCHERING CORP·Filed 1990·Granted Mar 2, 1993·39 cites·6 claims
- 0886US6214827B1Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1998·Granted Apr 10, 2001·34 cites·8 claims
- 0986US5712280ATricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Jan 27, 1998·35 cites·20 claims
- 1084US5608067A4-substituted pyrazoloquinoline derivativesFiled 1994·Granted Mar 4, 1997·25 cites·4 claims
- 1182US5179107AAntiviral quinolinone compoundsSCHERING CORP·Filed 1991·Granted Jan 12, 1993·23 cites·6 claims
- 1281US5378694AAcyl and alkoxy substituted quinolinesSCHERING CORP·Filed 1991·Granted Jan 3, 1995·49 cites·14 claims
- 1380US5179093AQuinoline-dionesSCHERING CORP·Filed 1991·Granted Jan 12, 1993·21 cites·12 claims
- 1480US4169141A1-Peptidyl derivatives of di-O-aminoglycosyl-1,3-diaminocyclitol antibacterial agentsSCHERING CORP·Filed 1978·Granted Sep 25, 1979·22 cites·29 claims
- 1578US5684013ATricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1995·Granted Nov 4, 1997·35 cites·8 claims
- 1677US5861395ACompounds useful for inhibition of farnesyl proteins transferaseSCHERING CORP·Filed 1997·Granted Jan 19, 1999·22 cites·32 claims
- 1776US6440989B2Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferaseSCHERING CORP·Filed 2001·Granted Aug 27, 2002·7 cites·8 claims
- 1874US6528522B2Substituted imidazoles as dual histamine H1 and H3 agonists or antagonistsSCHERING CORP·Filed 2001·Granted Mar 4, 2003·7 cites·19 claims
- 1974US5703090ATricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1996·Granted Dec 30, 1997·33 cites·8 claims
- 2074US5382572AAlkyl and acyl substituted quinolinesSCHERING CORP·Filed 1991·Granted Jan 17, 1995·16 cites·14 claims
- 2172US4347183AProcess for the synthesis of penems and carbapenemsSCHERING CORP·Filed 1981·Granted Aug 31, 1982·16 cites·16 claims
- 2271US4431658AAza penem compoundsSCHERING CORP·Filed 1982·Granted Feb 14, 1984·9 cites·3 claims
- 2370US6218401B1Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferaseSCHERING CORP·Filed 1999·Granted Apr 17, 2001·10 cites·5 claims
- 2469US5958939ATricyclic compounds useful for inhibition of a g-protein function and for treatment of proliferative diseasesSCHERING CORP·Filed 1997·Granted Sep 28, 1999·26 cites·8 claims
- 2569US4382949A2-(Amino acid-thio)-1-carbapen-2-em-3-carboxylic acids and congenersSCHERING CORP·Filed 1980·Granted May 10, 1983·8 cites·3 claims
- 2667US4448782A2-(Amino acid-thio)-2-penem-3-carboxylic acids and congenersSCHERING CORP·Filed 1981·Granted May 15, 1984·10 cites·13 claims
- 2765US5891872ATricyclic compoundsSCHERING CORP·Filed 1995·Granted Apr 6, 1999·11 cites·17 claims
- 2864US6740661B2Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 2001·Granted May 25, 2004·2 cites·23 claims
- 2963US5945429ACompounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1997·Granted Aug 31, 1999·8 cites·25 claims
- 3063US5506236A4-substituted pyrazoloquinoline derivativesSCHERING CORP·Filed 1994·Granted Apr 9, 1996·7 cites·12 claims
- 3162US5985879ACompounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1997·Granted Nov 16, 1999·9 cites·24 claims
- 3260US5595998APyrazoloquinolinesFiled 1994·Granted Jan 21, 1997·6 cites·17 claims
- 3360US4540579A2-[(R) Amino acid alkyl]penemsSCHERING CORP·Filed 1982·Granted Sep 10, 1985·4 cites·18 claims
- 3457US5459146A4-substituted pyrazoloquinoline derivativesSCHERING CORP·Filed 1993·Granted Oct 17, 1995·5 cites·11 claims
- 3557US4743598AAntibacterial 2-(azacycloalkyl) penemsSCHERING CORP·Filed 1982·Granted May 10, 1988·3 cites·12 claims
- 3654US4540580A2-[(1'R)-1'-Aminoalkyl]penemsSCHERING CORP·Filed 1982·Granted Sep 10, 1985·3 cites·29 claims
- 3751US5597821APyrazoloquinolinesFiled 1994·Granted Jan 28, 1997·3 cites·17 claims
- 3849US5942522AAntiviral compounds and antihypertensive compoundsSCHERING CORP·Filed 1997·Granted Aug 24, 1999·3 cites·8 claims
- 3949US2007213340A1Farnesyl protein transferase inhibitorsKELLY JOSEPH M·Filed 2007·Application pending·0 cites
- 4047US6130229ATricyclic compounds having activity as RAS-FPT inhibitorsSCHERING CORP·Filed 1997·Granted Oct 10, 2000·3 cites·11 claims
- 4146US6133291AN-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonistsSCHERING CORP·Filed 1998·Granted Oct 17, 2000·6 cites·27 claims
- 4238US5786480A4-substituted pyrazoloquinoline derivativesSCHERING CORP·Filed 1996·Granted Jul 28, 1998·1 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Adriano Afonso files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →